Sudarshan Pharma Industries Ltd
BSE: 543828
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q2 FY25 | Q4 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 165.66+4.6% | 158.37-5.2% | 167.01+17.4% | 142.31-48.7% | 277.16+23.0% | 225.35-3.6% | 233.76+0.8% | 231.80 |
| Other Income | 1.35-19.9% | 1.69-19.2% | 2.09+47.9% | 1.41-0.5% | 1.42-2.4% | 1.46+80.4% | 0.81-58.5% | 1.95 |
| Total Income | 167.01+4.3% | 160.06-5.3% | 169.10+17.7% | 143.73-48.4% | 278.58+22.8% | 226.81-3.3% | 234.57+0.4% | 233.74 |
| EXPENSES | ||||||||
| Expenditure | 158.88+2.7% | 154.65-5.9% | 164.27+18.6% | 138.53-47.4% | 263.52+21.0% | 217.76-3.7% | 226.04-0.5% | 227.18 |
| Tax | 2.10+88.8% | 1.11+161.4% | 0.42-70.9% | 1.46-57.7% | 3.45+76.5% | 1.96-5.6% | 2.07+24.0% | 1.67 |
| PROFIT | ||||||||
| PBT | 8.14+50.3% | 5.42+12.2% | 4.83-7.1% | 5.19-61.3% | 13.41+70.3% | 7.87-7.7% | 8.53+30.0% | 6.57 |
| Net Profit | 6.04+40.3% | 4.31-2.2% | 4.40+17.9% | 3.73-62.5% | 9.96+68.3% | 5.92-8.4% | 6.46+32.0% | 4.89 |
| KEY METRICS | ||||||||
| OPM % | 9.82%+3.02pp | 6.80%+1.05pp | 5.75%-1.48pp | 7.23%+6.16pp | 1.07%+1.89pp | -0.82%-1.37pp | 0.55%+0.20pp | 0.35% |
| NPM % | 3.62%+0.93pp | 2.69%+0.09pp | 2.60% | 2.60%-0.97pp | 3.57%+0.96pp | 2.61%-0.14pp | 2.75%+0.66pp | 2.09% |
| EPS | 0.25+38.9% | 0.18+0.0% | 0.18+20.0% | 0.15-63.4% | 0.41-83.3% | 2.46-8.2% | 2.68+32.0% | 2.03 |
Corporate Events
Board Meeting
The 18th Annual General Meeting of the members of Sudarshan …
BSE Filing ↗Board Meeting
The Board of Directors met and approved the acquisition of e…
BSE Filing ↗Board Meeting
A Meeting of the FCCB Committee of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors scheduled to be held t…
BSE Filing ↗Board Meeting
To consider and approve the migration of the company's equit…
BSE Filing ↗Board Meeting
consider and approve Pursuant to Regulation, Unaudited Stand…
BSE Filing ↗Board Meeting
considering and approving the proposal for sub-division / sp…
BSE Filing ↗Board Meeting
Authorization to appoint consultants and/or representatives.…
BSE Filing ↗Board Meeting
Consideration and approval of Un-Audited Standalone & Consol…
BSE Filing ↗Board Meeting
consider and approve the incorporation of a subsidiary compa…
BSE Filing ↗